-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Regencell Bioscience Holdings Ltd quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2019 to Q2 2024.
- Regencell Bioscience Holdings Ltd Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending June 30, 2024 was $2.79M, a 20.9% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)